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Abstract 
Despite the fact that several interventions for major depression have proven efficacy, a 
substantial number of patients are or become treatment resistant to various forms of 
pharmacotherapy and psychotherapy. Biological interventions that directly target brain 
activity such as electroconvulsive therapy are used to treat these patients, but some of these 
interventions are unlikely to be easily accepted because of their more invasive nature or side-
effects. The efficacy of non-invasive neurostimulation with a favorable side effect profile, 
such as repetitive Transcranial Magnetic Stimulation, could not be sufficiently demonstrated 
for treatment resistant depressed patients (TRD). We argue that research on the working 
mechanisms of these neurostimulation techniques is necessary to develop more efficient 
treatment protocols. After an overview of current neurostimulation approaches to treatment 
resistance and the introduction of a neurobiological and a cognitive framework of depression, 
we provide an integrative review of research on both the neurobiological and cognitive 
working mechanisms of neurostimulation in TRD, with a specific emphasis on the work of 
our lab. Thereafter, we describe our own studies and studies from other labs on new 
neurocognitive interventions. Finally we discuss how all this knowledge can be used to 
further develop new strategies to deal with treatment resistance, in combining 
neurostimulation and cognitive interventions. 
 
Keywords: Treatment Resistant Depression; tDCS; rTMS; Neurocognitive Training; 
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Neurostimulation as an intervention for treatment resistant depression: From research 
on mechanisms towards targeted strategies 
Introduction 
Major depressive disorder (MDD) is highly prevalent and is associated with serious 
personal suffering and societal costs (Kessler et al., 2010). The conceptualization of MDD as 
a psychological disorder has inspired the development of various forms of psychotherapy 
such as Cognitive Behavior Therapy (CBT), whereas the conceptualization of depression as a 
disorder of the brain has stimulated the use of different forms of pharmacotherapy such as 
Selective Serotonin Reuptake Inhibitors (SSRI). Many of these interventions have proven 
efficacy (Cuijpers et al., 2013) but relapse or recurrence rates are very high (Beshai, Dobson, 
Bockting, & Quigley, 2011). Moreover, in spite of the correct use of pharmacological or 
psychotherapeutic approaches, a substantial number of patients become treatment resistant (up 
to 15%) (Burrows, Norman & Judd, 1994; Fava, 2003). Neurobiological interventions that 
directly target brain activity such as Transcranial Magnetic Stimulation (TMS) are frequently 
used when patients do not respond to pharmacological interventions or psychotherapy. 
However, an important question is whether there is enough evidence to justify the application 
of these interventions for treatment resistant depression (TRD). We argue that research on the 
working mechanisms  of neurostimulation may be necessary for the development of more 
efficient treatment protocols. After an overview of current neurostimulation approaches to 
treatment resistance and the introduction of a neurobiological and a cognitive framework of 
depression, we provide an integrative review of research on both the neurobiological and 
cognitive working mechanisms of neurostimulation in TRD, with a specific emphasis on the 
work of our lab. Thereafter, we describe our own studies and studies from other labs on new 
neurocognitive interventions. Finally we discuss how all this knowledge can be used to 
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further develop new strategies to deal with treatment resistance, in combining 
neurostimulation and cognitive interventions. 
Neurostimulation Approaches to Treatment Resistance 
Electroconvulsive Therapy (ECT) is a biological intervention that has been used for several 
decades to treat patients with TRD (Kosel, Frick, Lisanby, Fisch, & Schlaepfer, 2003). In 
ECT, generalized seizures are electrically induced by electrodes focally placed on the scalp. 
ECT revealed to be a possible alternative for pharmaco-resistant patients, but during the 
course of such treatment general anesthetics have to be administrated multiple times, and in 
particular bi-temporal ECT may cause memory and learning impairments (Rami-Gonzalez et 
al., 2001). Although ECT has proven efficacy at the short term, based on a meta-analysis, it 
has been shown that despite continuation therapy with pharmacotherapy, the risk of relapse 
within the first year following ECT is substantial (> 50%), with the greatest risk for relapse 
within the first 6 months (>37%) (Jelovac, Kolshus, & McLoughlin, 2013).  
A variant of ECT is Magnetic Seizure therapy (MST). In MST, which has fewer 
cognitive side effects, focal seizure activity is induced by TMS (Lisanby, Luber, Schlaepfer, 
& Sackeim, 2003). In a small open label pilot clinical trial (N=13), 38,5 % of the depressed 
patients showed clinical response at the end of the study (Fitzgerald et al., 2013). This 
procedure may hold promise, but research on the use of MST is still very scarce and more 
research is needed to  determine its antidepressant properties and its utility for TRD (Wani, 
Trevino, Marnell, & Husain, 2013).  
A considerable amount of research has been performed using TMS, a non-invasive 
neurostimulation technique that is increasingly used. Electrical stimulation is delivered by an 
electromagnetic coil placed above the scalp in which a high-intensity current is rapidly turned 
on and off, producing a time-varying magnetic field. This magnetic field passes freely through 
the skin, muscle and skull to the surface of the brain, where it induces weak electric currents 
to flow in the underlying neurons. These neurons will be induced to fire if stimulation is 
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provided above a given threshold. Delivering trains of high-frequency (HF) (≥ 1 Hz) 
repetitive TMS (rTMS) pulses produces an increase in local cortical excitability after 
stimulation, whereas low-frequency (LF) stimulation (0.1– 1.0 Hz) decreases cortical 
excitability (Fitzgerald, Fountain, & Daskalakis, 2006). Although rTMS has been investigated 
as a treatment tool for various psychiatric disorders, most research has been done in major 
depression. Treatment protocols for depression consist mostly of 5-25 sessions of HF-rTMS 
to the left dorsolateral prefrontal cortex (DLPFC) or LF-rTMS applied to its right counterpart. 
A meta-analysis of 34 studies comparing rTMS to sham treatment showed a moderate effect 
size of 0.55 on depressive symptoms (Slotema, Blom, Hoek, & Sommer, 2010), whereas 
another meta-analysis of 30 HF-rTMS studies found an effect size of 0.39 (Schutter, 2009). 
Although these effect sizes are comparable to psychotherapy and pharmacotherapy 
(Roshanaei-Moghaddam et al., 2011), it is important to consider long term effects and 
treatment resistance to psychotropic agents.  
Disappointing effects  of TMS on remission are illustrated by the results of a well-
designed large scale (N = 190) prospective, multisite, randomized, sham-controlled, duration-
adaptive intention-to-treat study in depressed patients.  In a first phase, 3 weeks of daily 
weekday treatment (left DLPFC, 10 Hz) was followed by continued blinded treatment for up 
to another 3 weeks in improvers (patients who did not achieve full remission but a 30% 
reduction on the Hamilton Scale for Depression (HAM-D)) (George et al., 2010). The primary 
efficacy analysis of the initial intervention of 3 -6 weeks revealed a significant effect of 
treatment, but the number of remitters was modest (14.1% in the active and 5.1% in the sham 
condition), and importantly most remitters were not treatment resistant in the past. The latter 
is consistent with the results of another trial also suggesting that patients who have repeatedly 
failed other treatments tend to be less responsive to  rTMS (Lisanby et al 2009). In the open-
label follow-up second phase of 3-6 weeks treatment in patients who did not achieve a 30 % 
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reduction on their HAM-D score after the initial 3 week period of phase 1, only 30% remitted. 
The investigators correctly concluded that , although this kind of treatment produced a 
statistically significant effect on remission, the overall number of remitters and responders 
was less than one would like with a treatment requiring a daily intervention for 3 weeks or 
more. Moreover, few studies have assessed the long term effects of rTMS. In a large 
retrospective naturalistic study (Cohen, Boggio, & Fregni, 2009), a group of patients who 
remitted after both high and low frequency rTMS treatment were further followed up to 6 
months. During this period there were no further rTMS sessions, and medication was never 
introduced or changed after rTMS treatment. Event-free remission was 75.3% at 2 months, 
60.0% at 3 months, 42.7% at 4 months, and only 22.6% at 6 months. To summarize, although 
rTMS produces beneficial treatment effects in depression, the immediate effects on remission 
remain modest, the long term effects are limited, and treatment resistance seems to be a 
contra-indication.  
Even though a systematic review and meta-analysis of randomized trials showed that 
the reduction of depressive symptomatology was significantly more pronounced in ECT as 
compared to HF-rTMS (Berlim, Van den Eynde, & Daskalakis, 2013), rTMS has a more 
favorable side-effect profile and better tolerability (Baker, Trevino, McClintock, Wani, & 
Husain, 2012). Moreover, long term effects of ECT are not established as well. A study of 
Eranti et al. (2007) confirmed that ECT - as compared to rTMS - leads to a larger decrease in 
depressive symptoms as measured with the HAM-D, but at 6 months group differences 
disappeared. 
A recently developed variant of TMS is deep TMS. Deep TMS coils minimize the 
accumulation of electrical charge on the surface of the brain and maximize the electrical field 
deep in the brain by the summation of separate fields projected into the skull from several 
different points around its periphery (Roth, Amir, Levkovitz & Zangen, 2007). A review 
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comparing the efficacy and tolerability of deepTMS, rTMS and ECT in drug-free patients 
with pharmaco-resistant unipolar depression confirmed the superior efficacy of ECT as the 
most effective treatment option after 4 weeks of therapy. Deep TMS seems also to provide a 
substantial improvement of depressive symptoms but it is characterized by poorer tolerability, 
as witnessed by the highest dropout as compared to rTMS and ECT (Minichino et al., 2012). 
Another technique that yields growing interest is Transcranial Direct Current 
Stimulation (tDCS), an easy to use, safe, low-cost method. tDCS differs from TMS in that it 
can manipulate the membrane potential of neurons, but is not capable of directly activating 
the neurons itself (Paulus, 2011). Therefore it is often referred to as neuromodulation, 
whereas rTMS is referred to as neurostimulation. However in the reminder of this paper we 
will refer to both techniques as neurostimulation. tDCS uses a constant low current (1–2 mA, 
e.g. during 20 minutes) delivered directly to the brain area of interest via electrodes positioned 
on the scalp, inducing intracerebral current flows. The device has an anodal electrode (the 
positively charged electrode) and a cathodal electrode (the negatively charged electrode). One 
electrode (anode) is placed over the region of interest and the other electrode, the reference 
electrode (cathode), is placed in another location to create a circuit. Anodal tDCS enhances 
excitability, whereas cathodal tDCS reduces excitability (Nitsche & Paulus, 2000; Nitsche et 
al., 2005).  
Some clinical trials with multiple daily sessions yielded encouraging results in the 
treatment of depression. In a recent meta-analysis, active tDCS was found to be more 
effective than sham tDCS in reducing depression severity (Hedges’ g = .743) (Kalu, Sexton, 
Loo, & Ebmeier, 2012). Nonetheless, as concluded by several authors, its clinical utility 
remains unclear because there are not enough studies with large representative samples and 
optimized protocols to confirm the efficacy of tDCS (Brunoni, Ferrucci, Fregni, Boggio, & 
Priori, 2012; Kalu, Sexton, Loo, & Ebmeier, 2012), particularly for patients with TRD 
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(Valiengo et al., 2013). Recently researchers are also experimenting with high density tDCS, 
which uses smaller electrodes to more precisely target specific brain areas (Datta et al., 2009). 
The exact working mechanisms of all the abovementioned interventions, how they 
influence the brain circuitry involved in depression, remains poorly understood. Recent years 
have witnessed more targeted applications of neurostimulation to regions that have been 
implicated in disrupted emotion  processing known to be involved in TRD, such as the 
subgenual cingulate cortex (Ressler & Mayberg, 2007). Chronic Deep Brain Stimulation 
(DBS) of subgenual areas has yielded limited but promising initial results in small samples of 
TRD patients (Mayberg et al, 2005; Holtzheimer et al., 2012). In a systematic review and 
exploratory meta-analysis based on four observational studies in severe chronic TRD, twelve-
month response and remission rates were almost 40% and over 26% respectively (Berlim, 
McGirr, Van den Eynde, Fleck, & Giacobbe, 2014). However, this technique is invasive 
because it requires implanted electrodes and chronic application.  
Another invasive method to treat pharmaco-resistant depressed patients is Vagus Nerve 
Stimulation (VNS), in which the vagus is stimulated by implanted electrodes. A review based 
on a limited number of studies shows that it yields reductions in depressive symptomatology 
and high rates of remission in TRD patients but again, this intervention requires invasive 
surgery and continuous application (Rush & Siefert, 2009).  
To summarize, there are a number of biological treatment options for depressed patients 
who are not responsive to psychotherapy and pharmacotherapy that directly target brain 
activity, but many of these techniques are unlikely to be easily accepted by patients because 
(a) they require invasive interventions such as multiple anesthetics and surgery, (b) their 
efficacy is insufficiently demonstrated, or (c) they produce significant cognitive side effects. 
Given that we will argue (see further) that a combination of neurostimulation and cognitive 
interventions such as computerized cognitive control training might be an interesting option to 
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treat TRD, cognitive side effects are a contra-indication. Of all these neurobiological 
treatment techniques, rTMS and tDCS may be an excellent option for the combination with 
cognitive interventions because they are the least invasive and do not produce important side 
effects. Researchers have concluded that more research on the working mechanisms of these 
non-invasive neurostimulation techniques might be helpful to develop more efficient 
protocols (Fidalgo et al., 2014). We argue that we should take advantage of the increased 
understanding of the neurobiological and cognitive effects of neurostimulation.  
In the next section we provide an overview of our studies investigating the (1) 
neurobiological and (2) cognitive mechanisms of neurostimulation in TRD patients, guided by 
a neurobiological and a cognitive framework of depression respectively. 
Treatment Mechanisms of Neurostimulation in TRD 
A Neurobiological Framework of Depression 
Based on the observation that new depressive episodes are triggered by progressively 
milder stressors, it has been proposed that through stress-kindling new episodes are triggered 
more easily in response to stressors as compared with initial episodes (Monroe & Harkness, 
2005). In this perspective, we argue that recurrent MDD may evolve towards chronicity and 
treatment resistance because the neurocognitive protective mechanisms underlying stress 
resistance decline with the number of episodes (De Raedt & Koster, 2010).  
Depression has been conceptualized as a failure to recruit prefrontal top-down 
cognitive control to regulate emotion producing subcortical limbic activity (Phillips, 
Ladouceur, & Drevets, 2008). A meta-analysis of neuroimaging studies revealed evidence for 
the involvement of two neurocircuits in major depressive disorder. One network includes the 
dorsolateral prefrontal cortex (DLPFC) and dorsal (d) regions of the anterior cingulate cortex 
(ACC). These regions, among other regions which are implicated in attentional and cognitive 
control, are characterized by reduced activity during resting state, and return to normal with 
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successful treatment. A second network is centered on the medial prefrontal cortex and 
ventral subcortical regions such as the amygdala, which is hyperactive to emotional stimuli 
during depressive episodes, and also returns to normal after treatment (Fitzgerald, Laird, 
Maller, & Daskalakis, 2008). The amygdala is activated when people are confronted with 
emotionally challenging events (Zald, 2003), and is tightly connected to the ventral ACC. The 
ACC can be conceived as a bridge between subcortical emotion processing and prefrontal 
cognitive control, because it integrates signals from its ventral and dorsal parts (Bush, Luu, & 
Posner, 2000). The dorsal ACC sends signals to the DLPFC to enhance cognitive control 
(Hopfinger, Buonocore, & Mangun, 2000; MacDonald, Cohen, Stenger, & Carter, 2000) and 
studies suggest that the DLPFC initiates control over emotions by inhibition of the amygdala 
via other brain regions (Siegle, Thompson, Carter, Steinhauer, & Thase, 2007).  
 The fact that abnormalities in the abovementioned circuits are remediated after 
successful treatment (Fitzgerald et al., 2006) suggests that TRD might be characterized by an 
imbalance of ventral and dorsal systems. The connectivity network view, that a functional 
balance between ventral (ventral ACC) and dorsal compartments in the brain (dorsal ACC, 
DLPFC) may be necessary for maintaining homeostatic control over emotional information, 
has been confirmed by neuroimaging studies (for an overview, see Ochsner & Gross, 2005). 
Importantly, the subgenual cingulate region, which has been related to TRD (Mayberg, 2006; 
Baeken et al., 2010), has direct bidirectional connections to the amygdala and can be 
implicated in inhibitory control over the amygdala (Hamani et al., 2011). Depressed patients 
who are treatment resistant to CBT or pharmacotherapy exhibit pretreatment 
hypermetabolism at the interface of the pregenual and subgenual (sg)ACC (Konarski et al., 
2009). The association of the sgACC with acute sadness (Mayberg et al., 1999; Smith et al., 
2011), as well as with TRD (Ressler & Mayberg, 2007) is indicative of its crucial role in 
emotional reactivity. Consistent with this idea, in a study in which TRD female patients and 
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healthy controls were asked to passively view blocks of negative versus positive valenced 
baby faces while undergoing functional magnetic resonance imaging (fMRI), the depressed 
patients displayed higher bilateral sgACC activities in both emotional conditions as compared 
to the controls (Baeken et al., 2010).  
We argue that neurostimulation of the DLPFC might produce beneficial antidepressant 
effects through its influence on the abovementioned circuits, including the ACC and 
amygdala. Antidepressant working mechanisms of neurostimulation in depression can be 
considered on a scale from molecular over neural systems to cognition-emotion interactions 
(De Raedt & Koster, 2010). We start with an overview of studies on the neurobiological 
mechanisms of action. Thereafter we introduce a cognitive framework emphasizing the 
relationship with the neurobiological approach, followed by a review of research on the 
influence of neurostimulation on cognitive functions and cognitive-emotion interactions. We 
will look at each of these mechanisms and emphasize their relationship. 
Molecular Approach to Working Mechanisms of Neurostimulation 
George, Taylor and Short (2013) have suggested that rTMS may act as a ‘focal 
pharmacotherapy’ in a similar way as SSRIs. When a neuron fires provoked by rTMS, 
neurotransmitters are released in the synaptic cleft, causing increased functional connectivity. 
In a study using the radioligand123I-5-I-R91150 with single photon emission computed 
tomography in TRD patients, it could be demonstrated that the postsynaptic serotonin 5-HT2A 
receptors in dorsal regions of the prefrontal and the ACC are down-regulated compared to 
never depressed controls, whereas 5-HT2A receptor binding did not differ from controls in 
first-episode depressed patients (Baeken, De Raedt & Bossuyt, 2012). Based on these 
findings, the effect of 10 daily weekday HF-rTMS sessions applied to the left DLPFC on 
postsynaptic 5-HT2A receptor binding indices was examined in a group of antidepressant-free, 
pharmaco-resistant depressed (TRD) patients (Baeken et al, 2011). At baseline, the TDR 
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patients showed significantly less bilateral DLPFC and significantly higher left hippocampal 
5-HT2A receptor binding as compared to healthy controls. Successful HF-rTMS treatment was 
associated with increased 5-HT2A receptor binding in the DLPFC bilaterally and decreased 
right hippocampal 5-HT2A receptor binding, which is in line with the idea that rTMS may act 
as a focal pharmacotherapy intervention.  
Neural Systems Approach to Working Mechanisms of Neurostimulation 
The fact that effects were also observed in remote brain areas (relative to the area 
targeted by neurostimulation) is in line with prior findings suggesting that rTMS also 
influences brain connectivity with other areas such as the contralateral stimulation side and 
the ACC (Paus, Castro-Alamancos, & Petrides, 2001; Paus & Barrett, 2004). Circuits 
including these regions are linked to crucial cognitive risk factors for recurrent depression, 
namely rumination, impaired attentional control, and cognitive reactivity (Marchetti, Koster, 
Sonuga-Barke & De Raedt, 2012). Baeken, De Raedt and co-workers (2009a) observed that 
successful HF-rTMS treatment in TRD patients caused metabolic increases (glucose 
metabolism measured with 18Fluorodeoxyglucose Positron Emission Tomography: 18FDG-
PET) in dorsal subdivisions of the ACC, and that higher baseline metabolic activities in the 
DLPFC and the ACC are associated with better clinical outcome. The importance of looking 
at connectivity in circuits implied in TRD is underscored by research showing that limbic-
cortical connections (DLPFC-Subgenual Cingulate Cortex-Orbitofrontal cortex) can 
differentiate responders to pharmacotherapy from non-responders (Seminowicz et al., 2004).  
Inspired by the idea that rTMS influences brain connectivity, and the apparent role of 
the sgACC in emotional reactivity in TRD, Baeken et al. (2014) examined the effects of HF-
rTMS over the left DLPFC on resting state functional connectivity (fc) fMRI of the sgACC in 
TRD patients. First, at baseline, HF-rTMS responders compared to non-responders showed 
stronger fc anti-correlation between the sgACC and the left superior medial prefrontal cortex 
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compared to non-responders, which is similar to findings in other treatment modalities. 
Furthermore clinical response to HF-rTMS was associated with restored fc between sgACC 
and areas in the prefrontal cortex. The idea that these biological characteristics are related to 
functional mechanisms of decreased reactivity to stressful information is underscored by a 
study in which TRD patients received a single session of left-sided HF-rTMS to investigate 
the effects on the Hypothalamic Pituitary Adrenal axis. Although there were no changes in 
subjectively experienced mood, salivary cortisol concentrations, which is a measure of the 
physiological stress response, decreased significantly both immediately and 30 minutes after 
one active HF-rTMS session and not after sham (Baeken et al., 2009b).  
A Cognitive Framework of Depression and the Relationship with the Neurobiological 
Approach 
As proposed in the cognitive theory of depression (Beck, 1967; Clark, Beck & Alford, 
1999), information-processing is guided by schemas, which are memory structures containing 
information about the self, the world, and the future based on prior experiences. Specific 
attentional biases for depressogenic information filter external information leading to 
subjective negative experience. Importantly, these negative experiences further develop the 
maladaptive schemas causing a vicious cycle maintaining the disorder (Eysenck, 1997; 
Teasdale & Barnard, 1993). Numerous studies using different experimental paradigms have 
demonstrated that depression is characterized by attentional biases for negative information at 
later stages of information processing (for a review, see De Raedt & Koster, 2010). It has 
been demonstrated that this problem reflects difficulties to inhibit negative information 
(Goeleven, De Raedt, Baert, & Koster, 2006, see also Joorman, 2004) or to disengage 
attention away from external negative information (Leyman, De Raedt, Schacht, & Koster, 
2007). Although most of these studies have used visual cueing paradigms, evidence for 
control problems towards internal representations in depression could also be found (e.g. De 
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Lissnyder et al., 2012). Indeed, in cognitive psychology a distinction is made between 
external and internal attention (Chun, Golomb, &  Turk-Browne, 2011). In the remainder of 
this chapter, for reasons of clarity, we will use the generic term “cognitive control”, to refer to 
internal executive functions (e.g. shifting and updating in working memory), and “attentional 
control” to refer to visuospatial attentional functions for external information (e.g. 
disengagement from negative information).  
In several experimental studies using an internal shift task, it could be demonstrated 
that diminished cognitive control for mental representations – i.e. internal shifting 
impairments when negative information is held in working memory – is related to the 
tendency to ruminate (e.g. De Lissnyder, Koster & De Raedt, 2012). This impairment at 
baseline in a remitted depressed sample predicted depressive symptoms one year later, a 
relationship which was fully mediated by rumination (Demeyer, De Lissnyder, Koster, & De 
Raedt, 2012). Rumination, which has been defined as “behaviors and thoughts that focus one's 
attention on one's depressive symptoms and on the implications of those symptoms” (Nolen-
Hoeksema, 1991, p. 569), is associated with depressive symptoms and is predictive of future 
depressive episodes and their duration (Nolen-Hoeksema, 2000), severity (Just & Alloy, 
1997) as well as of recovery from depression (Kuehner & Weber, 1999). This indicates that 
rumination is an important cognitive vulnerability factor for depression. It has also been 
demonstrated that the DLPFC is implied in the neurocircuit associated with rumination 
(Vanderhasselt, Kuhn, & De Raedt, 2011). In healthy non-depressed individuals, those who 
tend to ruminate in daily life displayed higher DLPFC involvement when they successfully 
inhibit negative information during a cognitive control task (emotional GO/NOGO paradigm). 
These data suggest that healthy individuals who tend to ruminate need to recruit more 
cognitive control in order to disengage successfully from negative information. The fact that 
the involvement of dorsal areas might be a vulnerability factor is underscored by the 
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observation that rumination is also associated with volume and resting state reductions in 
brain areas that have been linked to cognitive control processes such as prefrontal areas and 
the ACC (Kuhn, Vanderhasselt, De Raedt & Gallinat, 2012).  
To summarize, in TRD patients (see supra) abnormalities are observed in dorsal 
compartments at the level of neurotransmitters and at the level of connectivity with regions 
implied in cognitive and attentional control and rumination. This may explain how the 
neuroanatomical and functional correlates of treatment resistance may be related to core 
symptoms of depression such as rumination. This prompted us to develop a framework to 
explain the increasing vulnerability for depression after multiple episodes – which can lead to 
treatment resistance – integrating experimental psychopathology and neurocognitive research. 
The basic idea of this framework is that prolonged processing of self-referent material such as 
rumination - after the activation of negative schemas - is caused by impaired activity in dorsal 
prefrontal areas, mediated by the serotonergic system which is under control of the 
Hypothalamic Pituitary Adrenal (HPA) axis. The HPA axis – the hallmark of the stress 
response – stimulates the release of stress hormones (corticosteroids), and becomes 
increasingly impaired after periods of hypercortisolism during depressive episodes (van 
Praag, De Kloet & van Os, 2004), which means that it becomes more reactive to stressors (De 
Raedt & Koster, 2010). 
Interestingly, it has been shown that mood repairing psychological processes such as 
reappraisal of negative information are related to recruitment of the same dorsal areas. 
Healthy individuals who tend to use reappraisal to overcome negative affect in daily life were 
behaviorally faster and exerted more dACC activity when inhibiting a response to negative in 
favor of positive information (compared to inhibiting a positive in favor of a negative 
response) (Vanderhasselt, Baeken, Van Schuerbeek, Luypaert, & De Raedt, 2013).  
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In the next paragraphs we will explore the relationship between the neural systems that 
are influenced by rTMS of the DLPFC and emotional reactivity, attentional control, cognitive 
control and emotion regulation. 
Cognitive Approach to Working Mechanisms of Neurostimulation 
Based on a review (Pringle, Browning, Cowen, & Harmer, 2011), it has been 
hypothesised that pharmacotherapy (SSRIs) might act through its influence on attentional 
control over negative information. In a series of studies, it has been investigated whether HF-
rTMS of the DLPFC might work through its influence on attentional and cognitive control. 
Vanderhasselt and co-workers examined the effects of a single session and 10 sessions during 
2 weeks of HF-rTMS over the left DLPFC on attentional control using a task switching 
paradigm in TRD patients (crossover placebo-controlled double-blind design) (Vanderhasselt, 
De Raedt, Leyman & Baeken, 2009). After 2 weeks of stimulation, depressive symptoms 
improved in more than half of the therapy-resistant patients. After the single session, mood 
did not improve but attentional control was increased solely within the group of treatment 
responders. This suggests that rTMS activates a network implied in attentional control in TRD 
patients who show remission. Furthermore, it has been shown that deficiencies in cognitive 
control (as measured using ACC related Event Related Potentials (ERP) during a cognitive 
control task that requires conflict resolution) are correlated with the number of prior episodes, 
suggesting that with every episode control further declines (Vanderhasselt & De Raedt, 2009). 
In another small pilot study emotion specific results have been found. After two weeks of 
daily HF-rTMS of the left DLPFC, 9 out of 14 of severely depressed patients demonstrated 
clinical significant improvement, and these responders also demonstrated significant 
improvements in the inhibitory control for negative information (sad faces) (Leyman, De 
Raedt, Vanderhasselt & Baeken, 2011). This indicates that the antidepressant effect of rTMS 
may be related to decreased deficiencies in inhibitory control towards negative information. 
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However, in the latter study the changes in attentional processes might be caused by HF-
rTMS induced symptom changes. Therefore it is also important to examine causal 
mechanisms in never depressed participants. By using a single placebo-controlled HF-rTMS 
session, De Raedt et al. (2010) experimentally manipulated activity within the right DLPFC of 
healthy participants to induce prefrontal asymmetry with higher right sided brain activity just 
as observed in depressed patients (Davidson, Pizzagalli, Nitschke, & Putnam, 2002), and 
examined changes in attentional control for emotional information (angry faces) using an 
emotional modification of a spatial cueing task during event-related fMRI. This stimulation of 
the right DLPFC resulted in impaired disengagement from negative information, just as 
observed in currently depressed patients (Leyman, De Raedt, Schacht & Koster, 2007). 
Moreover, this was associated with decreased activation in the right DLPFC, dACC and left 
superior parietal gyrus, combined with increased activity within the right amygdala during 
disengagement away from negative information. Depression specific attentional control 
deficiencies could be induced in healthy individuals, affecting regions that are implicated in 
the neurocircuits involved in emotion regulation but without any effects on mood. This 
underscores the possible causal influence of HF-rTMS of the DLPFC on attentional control, 
and that these mechanisms might be implied in the antidepressant outcome of rTMS. 
Combining Cognitive Interventions with Neurostimulation 
So far we provided evidence that rTMS of the left DLPFC influences neurocircuits 
involved in rumination, cognitive control, attentional control and emotion regulation. 
Moreover, rTMS seems to act by restoring receptor sensitivities in postsynaptic receptor 
binding in the prefrontal cortex and connectivity between prefrontal areas and other areas 
implied in emotional reactivity and emotion regulation such as the ACC and the amygdala. 
Most importantly, rTMS seems not capable of causing stable remission in TRD despite the 
neurobiological and cognitive effects described in the former sections. This suggests that we 
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might do well to also influence the abovementioned cognitive and attentional control 
processes more directly in addition to the neurostimulation sessions. These cognitive 
processes (1) are known to be influenced by neurostimulation, and (2) are a vulnerability to 
depression. This could facilitate neuroplasticity, which is a core mechanism underlying new 
learning. Indeed, although the basic wiring of the central nervous system is genetically pre-
programmed, its fine-tuning during the life span is experience-dependent (Post & Weiss, 
1997). This experience-dependent neuroplasticity enables all forms of cognitive processes and 
changes of these processes. Neurons are able to modulate the strength and structure of their 
interconnections as a result of experience and training of specific behavior (Martin & Kandel, 
1996; Krasne, 2002). In order for a treatment to be successful at the long term, changes at the 
structural and functional brain level related to cognitive and attentional control may be 
required. Although rTMS and tDCS are able to induce and modulate neuroplasticity (Kuo, 
Paulus & Nitsche, 2014), training (learning) may be a means to strengthen these effects, 
making them more specific to cognitive functions which are disabled in TRD. Thus, 
neuromodulation may cause unspecific neuroplasticity changes, whereas the combination 
with training might create more targeted neuroplasticity changes. The effects of 
neurostimulation could thus be boosted by combining these techniques with training of 
cognitive strategies that foster new learning and thus facilitate plasticity. In the next sections, 
we will focus on different specific targets for training: (1) cognitive control towards internal 
mental presentations and (2) attentional control, i.e. disengagement from negative external 
information. tDCS is particularly suitable to be combined with training because both 
procedures can be administered at the same time, whereas rTMS can be disruptive during 
stimulation (Fidalgo et al., 2014) (and training should thus start after rTMS). Moreover, there 
are indications that tDCS has similar effects on cognitive functions as rTMS (for a review, see 
Kuo & Nitsche, 2012).  
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Cognitive Control 
Siegle and colleagues (Siegle, Price, Jones, Ghinassi, Painter & Thase, 2014) used a 
DLPFC related cognitive control training (CCT) procedure to increase cognitive control, as an 
add-on to medication and psychotherapy in severely depressed patients (but not TRD). They 
applied six sessions of cognitive control exercises that consist of working memory training 
that engages the prefrontal cortex (Paced Auditory Serial Addition Task, PASAT, Gronwall, 
1977) combined with attentional training for external auditory information (Papageorgiou & 
Wells, 2000) as an add-on to treatment-as-usual (TAU: medication & psychotherapy). As 
compared to TAU only, CCT + TAU resulted in decreased rumination, early reduction in 
depressive symptomatology, and less use of intensive outpatient services during the following 
year. In a subsample of six individuals, these authors also used fMRI assessment before and 
after the training. The results showed that after the intervention, depressed participants 
displayed decreased disruptions in both amygdala activity on an emotion task and in DLPFC 
activity on a cognitive task on which they were not trained (Siegle, Ghinassi & Thase, 2007). 
This is a first study showing that a combination of regular approaches and cognitive control 
training may have extra value in the treatment of depression. But what about medication 
resistant patients? Given that rTMS is capable to influence neurocircuits implied in cognitive 
and attentional control in TRD patients, but that TRD seems to weaken the effects of rTMS, a 
next step might be to use CCT as an add-on to neurostimulation in these patients. This might 
be a more potent strategy to influence depression vulnerability. In a pilot study, tDCS has 
been used to test this proof-of-principle. 
 Segrave and colleagues (Segrave, Arnold, Hoy, & Fitzgerald, 2013) used the 
abovementioned CCT (Siegle et al., 2014) in combination with tDCS of the left DLPFC 
during 5 consecutive daily sessions. Twenty-seven MDD patients were randomized into three 
conditions: tDCS combined with CCT, sham tDCS combined with CCT and sham CCT. 
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There was a similar reduction in depression severity at the end of the procedure in all three 
treatment conditions. However, only the tDCS plus CCT condition resulted in sustained 
antidepressant response at three weeks follow up, and the magnitude of this effect was greater 
than the one observed immediately following the treatment procedure. This provides a 
preliminary proof-of-principle for the use of concurrent CCT and tDCS, but the sample size 
was very small, these patients were not treatment resistant and the limited extra value could 
only be demonstrated at follow-up. In a similar double-blind trial (Brunoni et al., 2014), 
participants were randomized to sham tDCS and CCT (n=17) vs. active tDCS and CCT 
(n=20) during 10 consecutive workdays. Here, only the DLPFC-related working memory 
training (PASAT) was used. Both CCT alone and combined with tDCS were successful in 
decreasing depressive symptoms after the acute treatment period and at follow-up, with a 
response rate of approximately 25%. However, older patients and those who presented better 
performance in the task throughout the trial showed greater depression improvement in the 
tDCS with CCT treatment group.  
Given that depression is characterized by emotion specific cognitive control problems, 
a crucial improvement may be to use a working memory paradigm that is emotion specific. In 
a placebo-controlled within subjects study in healthy individuals, anodal tDCS over the left 
DLPFC (cathode over the right supraorbital region) was applied during performance of an 
internal shift task (in which participants have to shift and update emotional information in 
working memory) during one session. Twenty minutes after neurostimulation, the occurrence 
of momentary self-referent ruminative thought was assessed during a rest period. The 
influence of tDCS (and not placebo) on ruminative thought was mediated by increased 
shifting ability away from negative to neutral information (Vanderhasselt, Brunoni, Loeys, 
Boggio & De Raedt, 2013). Although the task used in this study was not a training task but 
only a task to measure cognitive control, these findings in healthy individuals suggest that by 
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training the ability to update and shift away from negative representations in working 
memory, combined with tDCS, might help patients to specifically control their ruminative 
thoughts.  
To summarize, combining cognitive training and neurostimulation may hold promise, 
but more research is needed to further elaborate these findings in depressed and TRD patients. 
Moreover, depression is not only characterized by cognitive control problems for internal 
mental representations, but also for external negative information (De Raedt & Koster, 2010) 
which will be discussed in the following paragraph.  
Attentional Control 
As already mentioned, in many studies it has been observed that depression is 
characterized by biased visual attention for mood-congruent information, specifically 
difficulties with disengagement from negative information (for a review, see De Raedt & 
Koster, 2010). In this perspective, therapies could help patients to create new experiences by 
influencing how they perceive their environment, exposing them to schema incompatible 
information by using attention training to automatize attention away from negative towards 
positive information (Baert, Koster & De Raedt, 2011). In two experiments, one in dysphoric 
students and one in depressed patients, Baert and co-workers (Baert, De Raedt, Schacht & 
Koster, 2010), examined the effects of such an intensive internet delivered attention training 
procedure during 10 daily sessions. Whereas attention bias was not differentially influenced 
compared to a control procedure in both experiments, the undergraduates showing mild 
depressive symptoms improved on symptom severity in the active training condition. 
However, depressive symptoms increased after the training in the ones showing moderate to 
severe depressive symptoms. In depressed patients, no beneficial effects on top of therapy and 
medication (TAU) were observed. These results suggest that depressed patients might not 
benefit from attention training procedures to automatize attention away from negative towards 
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positive information. A recent meta-analysis confirms that there is currently no evidence for a 
beneficial effect of attentional bias retaining using visual cueing paradigms (Hallion & 
Ruscio, 2011).  
Nonetheless, it could be demonstrated that a similar attention training procedure has 
beneficial effects in recovered depressed patients (Browning, Holmes, Charles, Cowen, & 
Harmer, 2012). Interestingly, Browning and colleagues have shown in healthy individuals that 
the modification of attentional bias by an attention training procedure (to train attentional 
disengagement away from negative information) altered DLPFC activation to emotional 
stimuli. This indicates that this form of training can influence brain processes which are 
dysfunctional in depression (Browning, Holmes, Murphy, Goodwin, & Harmer, 2010). 
Depressed patients might show no benefits of attention training because of dysfunctional 
activity in their DLPFC, which is related to this training. This means that combining attention 
training with neurostimulation may be beneficial.  
In a recent study of Clarke and colleagues (in press) preliminary evidence is provided 
that anodal tDCS of the left DLPFC increases the effects of attention training in healthy 
participants. They induced attentional bias either towards or away from threat words, and 
participants received either tDCS or placebo during this training paradigm. Only participants 
receiving real tDCS showed more evidence of an attentional bias change in the targeted 
direction (towards or away from threat).  
The results of another recent study in social anxious  individuals provided further 
evidence that anodal tDCS applied to the left DLPFC may enhance the effects of attention 
training. Attention training (away from negative information), was combined with tDCS (both 
anodal and cathodal) versus sham stimulation. The only procedure that yielded effects was the 
anodal tDCS condition, which caused decreased total dwell time on angry faces as measured 
by eye movement registration (Heeren, Baeken,Vanderhasselt, Philippot, & De Raedt, 2014).   
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Although this latter study was conducted in social anxious individuals, and further 
research in depressed and TRD patients is thus needed, the results are indicative of the 
possibilities of combining attention training with neurostimulation. Given that both 
neurostimulation and attentional control training seem to target similar neurocircuits, 
combining them may have important added value. As suggested by Segrave, Arnold, Hoy and 
Fitzgerald (2013), stimulating brain circuits that are activated by cognitive procedures might 
produce better results as compared to stimulation alone. Moreover, by combining 
neurostimulation with more specific training procedures, patients also acquire new learning 
on how to use their improved brain functioning (e.g to disengage from negative thoughts or 
from external information). Despite the fact that there are currently no studies in TRD 
patients, the results of the abovementioned studies are encouraging for our approach.  
Conclusion and Implications for Future Research 
Current invasive treatment options -including ECT- to deal with TRD are unlikely to 
be easily accepted by many patients and their caregivers because they produce cognitive side 
effects, require anesthetics or surgery, or their long term outcome is insufficiently 
demonstrated. The latter suggests that such biological treatment options remain insufficiently 
effective in diminishing underlying vulnerability factors. We argue that, in order to achieve 
long lasting treatment effects of neurostimulation applications, new learning to facilitate brain 
plasticity should take place. On the one hand, the effects of non-invasive neurostimulation on 
neuroplasticity could be fine-tuned by combining it with training strategies that activate the 
circuits implied in specific cognitive functions. On the other hand the positive effects of 
cognitive training could be facilitated by stimulating the circuits involved in the processes that 
are trained.   
Based on this review, we propose that future research should be focused on the 
development of a new generation of treatment strategies combining biological and cognitive 
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interventions. To treat TRD with long term results, instead of using monotherapeutic 
interventions it could be necessary to influence its underlying pathophysiology by using a 
combination of different complementary strategies that are related to similar brain processes. 
In order for a treatment to be successful at the long term, changes at the structural and 
functional brain level associated with the disabled cognitive functions might be required, and 
the combination of neurostimulation and cognitive training could be a means to achieve this. 
Novel therapeutic strategies should be further developed, combining neurostimulation 
techniques targeting specific parts of the brain with cognitive control training (i.e. working 
memory) to increase the ability to shift away from ruminative thinking, and attentional bias 
training to automatize attention away from negative information in the environment. 
Nonetheless, it is obvious that this research domain is still in its infancy. Therefore, an 
important avenue for further research is to develop new potent cognitive and attentional 
training procedures. Furthermore, the added value of these complementary techniques to 
increase response rates and reductions of relapse and long term effects in TRD patients, 
should be investigated. In addition, the necessary doses of training sessions should be 
established, and predictors of successful outcome need to be examined. Given the differences 
in neurobiological pathways for subtypes of depression (Sharpley & Bitsika, 2013), it is also 
crucial for this type of interventions to define what works best for whom. 
To conclude, different strategies that target different aspects of similar underlying 
processes could be combined. This should enhance emotion regulation abilities to foster the 
development of more adaptive schemas of the self and the environment, and to ultimately 
increase resilience for future depressive episodes.  
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